Merck & Co., Inc. (MRK)
NYSE: MRK · IEX Real-Time Price · USD
130.20
-1.64 (-1.24%)
At close: Jun 12, 2024, 4:00 PM
130.60
+0.40 (0.31%)
Pre-market: Jun 13, 2024, 5:26 AM EDT
Merck & Co. Revenue
Merck & Co. had revenue of $61.40B in the twelve months ending March 31, 2024, with 6.11% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $15.78B with 8.89% year-over-year growth. In the year 2023, Merck & Co. had annual revenue of $60.12B with 1.40% growth.
Revenue (ttm)
$61.40B
Revenue Growth
+6.11%
P/S Ratio
5.37
Revenue / Employee
$852,806
Employees
72,000
Market Cap
329.77B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 60.12B | 832.00M | 1.40% |
Dec 31, 2022 | 59.28B | 10.58B | 21.72% |
Dec 31, 2021 | 48.70B | 7.19B | 17.31% |
Dec 31, 2020 | 41.52B | 2.40B | 6.13% |
Dec 31, 2019 | 39.12B | -3.17B | -7.50% |
Dec 31, 2018 | 42.29B | 2.17B | 5.41% |
Dec 31, 2017 | 40.12B | 315.00M | 0.79% |
Dec 31, 2016 | 39.81B | 309.00M | 0.78% |
Dec 31, 2015 | 39.50B | -2.74B | -6.48% |
Dec 31, 2014 | 42.24B | -1.80B | -4.08% |
Dec 31, 2013 | 44.03B | -3.23B | -6.84% |
Dec 31, 2012 | 47.27B | -780.00M | -1.62% |
Dec 31, 2011 | 48.05B | 2.06B | 4.48% |
Dec 31, 2010 | 45.99B | 18.56B | 67.66% |
Dec 31, 2009 | 27.43B | 3.58B | 15.00% |
Dec 31, 2008 | 23.85B | -347.70M | -1.44% |
Dec 31, 2007 | 24.20B | 1.56B | 6.90% |
Dec 31, 2006 | 22.64B | 624.10M | 2.84% |
Dec 31, 2005 | 22.01B | -960.90M | -4.18% |
Dec 31, 2004 | 22.97B | 486.90M | 2.17% |
Dec 31, 2003 | 22.49B | 1.04B | 4.85% |
Dec 31, 2002 | 21.45B | 246.80M | 1.16% |
Dec 31, 2001 | 21.20B | -19.16B | -47.48% |
Dec 31, 2000 | 40.36B | 7.65B | 23.38% |
Dec 31, 1999 | 32.71B | 5.82B | 21.62% |
Dec 31, 1998 | 26.90B | 3.26B | 13.80% |
Dec 31, 1997 | 23.64B | 3.81B | 19.21% |
Dec 31, 1996 | 19.83B | 3.15B | 18.87% |
Dec 31, 1995 | 16.68B | 1.71B | 11.43% |
Dec 31, 1994 | 14.97B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 379.49B |
Johnson & Johnson | 81.80B |
AbbVie | 54.40B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.49B |
Abbott Laboratories | 40.33B |
Eli Lilly | 35.93B |
MRK News
- 1 day ago - Merck looks for next-generation opportunities in obesity - Reuters
- 7 days ago - Merck Completes € 180 Million Investment to Expand Schnelldorf Distribution Center - Business Wire
- 7 days ago - Merck to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference - Business Wire
- 8 days ago - What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck - Forbes
- 9 days ago - Moderna, Merck say vaccine improved survival in patients with deadly skin cancer - CNBC
- 9 days ago - Merck's Innovative Oncology Pipeline of DNA Damage Response Inhibitors and Antibody-Drug Conjugates Poised to Advance Cancer Treatment - Business Wire
- 9 days ago - Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up - Reuters
- 9 days ago - Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in Recurrence-Free Survival & Distant Metastasis-Free Survival Versus KEYTRUDA in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection - Accesswire